Accelerated hippocampal atrophy in Alzheimer's disease with apolipoprotein E ε4 allele
暂无分享,去创建一个
Hiroaki Kazui | Minoru Yasuda | Mieko Matsui | Etsuro Mori | E. Mori | H. Kazui | N. Hirono | M. Hashimoto | Kanguk Lee | M. Matsui | Mamoru Hashimoto | Nobutsugu Hirono | M. Yasuda | KangUk Lee
[1] K. Davis,et al. The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy. , 1983, Psychopharmacology bulletin.
[2] S. Corkin,et al. Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease , 1996, Neurology.
[3] H. Soininen,et al. Longitudinal SPECT study in Alzheimer’s disease: relation to apolipoprotein E polymorphism , 1998, Journal of neurology, neurosurgery, and psychiatry.
[4] A. Kurz,et al. Apolipoprotein E epsilon 4 allele, cognitive decline, and deterioration of everyday performance in Alzheimer's disease , 1996, Neurology.
[5] C. Jack,et al. MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease , 1992, Neurology.
[6] S. Resnick,et al. Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype , 2000, Neurology.
[7] C. Jack,et al. Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease , 1998, Neurology.
[8] E G Tangalos,et al. Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease , 1998, Annals of neurology.
[9] Hiroaki Kazui,et al. Apolipoprotein E ε4 and the pattern of regional brain atrophy in Alzheimer’s disease , 2001, Neurology.
[10] PhilipR. Wenham,et al. Apolipoprotein E genotyping by one-stage PCR , 1991, The Lancet.
[11] R. Brookmeyer,et al. Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease. , 1996, Archives of neurology.
[12] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[13] H. Soininen,et al. Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: Correlation with memory functions , 1995, Journal of neural transmission. Parkinson's disease and dementia section.
[14] Steven D. Edland,et al. Accelerated decline in apolipoprotein E-ϵ4 homozygotes with Alzheimer's disease , 1998, Neurology.
[15] A. M. Saunders,et al. Apolipoprotein E ϵ4 allele and hippocampal volume in twins with normal cognition , 1997, Neurology.
[16] E G Tangalos,et al. Apolipoprotein E genotype influences cognitive ‘phenotype’ in patients with Alzheimer's disease but not in healthy control subjects , 1998, Neurology.
[17] R. Brookmeyer,et al. Apolipoprotein E genotype and rate of decline in probabole Alzheimer's disease , 1996 .
[18] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[19] K. Welsh-Bohmer,et al. Apolipoprotein E epsilon 4 allele and hippocampal volume in twins with normal cognition. , 1997, Neurology.
[20] K. Ishii,et al. Lack of Association of Apolipoprotein E ε4 Allele Dose with Cerebral Glucose Metabolism in Alzheimer Disease , 1998 .
[21] E. Mori,et al. Clinical Diagnosis of Dementia with Lewy Bodies in a Japanese Dementia Registry , 1999, Dementia and Geriatric Cognitive Disorders.
[22] E B Larson,et al. Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease. , 1998, Neurology.
[23] Charles DeCarli,et al. APOE-ε4 is associated with less frontal and more medial temporal lobe atrophy in AD , 1999, Neurology.
[24] E. Mori,et al. Amygdalar volume and emotional memory in Alzheimer's disease. , 1999, The American journal of psychiatry.
[25] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[26] H. Soininen,et al. SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele. , 1996, Journal of neurology, neurosurgery, and psychiatry.
[27] Daniel Bandy,et al. Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease , 1998, Annals of neurology.
[28] C. Jack,et al. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD , 2000, Neurology.
[29] C. Jack,et al. MRI‐Based Hippocampal Volume Measurements in Epilepsy , 1994, Epilepsia.
[30] J. Yesavage,et al. No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease. , 1997, The American journal of psychiatry.
[31] S Kobashi,et al. Frontotemporal dementia and Alzheimer disease: evaluation of cortical atrophy with automated hemispheric surface display generated with MR images. , 1998, Radiology.
[32] E. Mori,et al. Medial temporal structures relate to memory impairment in Alzheimer’s disease: an MRI volumetric study , 1997, Journal of neurology, neurosurgery, and psychiatry.
[33] H. Soininen,et al. SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E £4 allele , 2022 .
[34] H. Soininen,et al. Apolipoprotein E, memory and Alzheimer's disease , 1996, Trends in Neurosciences.
[35] Yutaka Hata,et al. Automated segmentation of human brain MR images aided by fuzzy information granulation and fuzzy inference , 2000, IEEE Trans. Syst. Man Cybern. Part C.
[36] E. Mori,et al. Medial temporal and whole-brain atrophy in dementia with Lewy bodies , 1998, Neurology.
[37] E. Corder,et al. Apolipoprotein E Genotype and Rate of Decline in Probable Alzheimer's Disease , 1996 .
[38] Minoru Yasuda,et al. Apolipoprotein E ε4 Allele and Whole Brain Atrophy in Late-Onset Alzheimer's Disease , 1998 .